Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Delayed Hypersensitivity

zidovudine has been researched along with Delayed Hypersensitivity in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.67)18.7374
1990's12 (80.00)18.2507
2000's2 (13.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
French, MA; James, IR; Mallal, SA1
Gordin, FM; Hamilton, JD; Hartigan, PM; Klimas, NG; Simberkoff, MS; Zolla-Pazner, SB1
Cameron, P; Cohn, Z; Kaplan, G; Meyn, P; Montana, A; Smith, K; Teppler, H1
Carter, WA; Hamill, AK; Klimas, N; Molavi, A; Salvato, PD; Strayer, DR; Thompson, CE; Thompson, KA; Ventura, D; Zheng, Z1
Carlo, DJ; Daigle, AE; Ferre, F; Jensen, FC; Levine, A; Moss, RB; Richieri, SP; Salk, J; Trauger, RJ; Truckenbrod, A; Turner, J1
Cooper, DA; Gow, I; Harris, J; Jaramillo, AB; Kelleher, AD; McMurchie, M; Patou, G; Roggensack, M; Smith, DE; Walker, A1
Chiozzi, MH; Connick, E; Fox, L; Kessler, H; Kotzin, BL; Kuritzkes, DR; Landay, A; Lederman, MM; Leonard, JM; Martinez, A; Roe, JD; Rousseau, F; Spritzler, J; St Clair, M; Wade, M1
Boyle, B; Corral, LG; Elbeik, T; Haslett, PA; Kaplan, G; Klausner, JD; Kunachiwa, W; Makonkawkeyoon, S; Maneekarn, N; Metatratip, P; Moreira, A; Shen, Z; Vongchan, P1
Chiozzi, MH; Connick, E; D'Arc Roe, J; Fox, L; Kessler, H; Kotzin, BL; Kuritzkes, DR; Landay, A; Lederman, MM; Leonard, JM; Martinez, A; Rousseau, F; Sevin, AD; Spritzler, J; St Clair, M1
Connick, E; Evans, TG; Fox, L; Heath-Chiozzi, M; Kessler, H; Kuritzkes, DR; Landay, A; Lederman, HM; Lederman, MB; Lederman, MM; Roe, J; Smith, KY; Spritzler, J; Valdez, H1
Dawkins, RL; French, MA; Mallal, SA1
Merigan, TC; Schwartz, DH; Skowron, G1
Borleffs, JC; Bosboom-Kalsbeek, KC; Gmelig-Meyling, FH; Hoepelman, AM; Schuurman, HJ; Vrehen, HM1
Cameron, PU; Dawkins, RL; French, MA; Grimsley, G; Smyth, LA1
Diven, DG; Newton, RC; Ramsey, KM1

Trials

10 trial(s) available for zidovudine and Delayed Hypersensitivity

ArticleYear
Detection of subclinical Mycobacterium avium intracellulare complex infection in immunodeficient HIV-infected patients treated with zidovudine.
    AIDS (London, England), 1994, Volume: 8, Issue:9

    Topics: AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cohort Studies; HIV Infections; Humans; Hypersensitivity, Delayed; Longitudinal Studies; Mycobacterium avium-intracellulare Infection; Prospective Studies; Tuberculin Test; Zidovudine

1994
Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. Department of Veterans Affairs Cooperative Study Group.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cohort Studies; Double-Blind Method; Female; HIV Infections; Humans; Hypersensitivity, Delayed; Leukocyte Count; Male; Prognosis; Proportional Hazards Models; Risk Factors; Skin Tests; Survival Rate; Treatment Outcome; Zidovudine

1994
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:polyC12U in the treatment of HIV infection.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiviral Agents; Candida albicans; CD4 Lymphocyte Count; Cross-Over Studies; Disease Progression; Double-Blind Method; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Core Protein p24; HIV Infections; Humans; Hypersensitivity, Delayed; Male; Middle Aged; Mumps; Poly I-C; Poly U; RNA, Double-Stranded; Skin Tests; Tetanus; Trichophyton; Zidovudine

1996
Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIV-1 immunogen and antiviral drug therapy.
    Journal of clinical immunology, 1996, Volume: 16, Issue:5

    Topics: AIDS Vaccines; CD4 Lymphocyte Count; Didanosine; Drug Therapy, Combination; HIV Envelope Protein gp120; HIV Infections; Hypersensitivity, Delayed; Immunotherapy, Active; Viral Load; Zidovudine

1996
Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects. Community HIV Research Network Investigators.
    AIDS (London, England), 1998, Jan-22, Volume: 12, Issue:2

    Topics: Adult; AIDS Vaccines; Anti-HIV Agents; CD4 Lymphocyte Count; Combined Modality Therapy; Disease Progression; Female; HIV Antibodies; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Lymphocyte Count; Male; Middle Aged; Treatment Outcome; Vaccination; Viral Load; Zidovudine

1998
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:1

    Topics: Adult; Anti-HIV Agents; Antigens; B-Lymphocytes; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Antigens; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypersensitivity, Delayed; Lamivudine; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocyte Subsets; Time Factors; Zidovudine

1998
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.
    AIDS research and human retroviruses, 1999, Sep-01, Volume: 15, Issue:13

    Topics: Adult; Anti-HIV Agents; Cytokines; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Interleukin-2; Lamivudine; Lymphocyte Activation; Male; T-Lymphocytes; Thalidomide; Viral Load; Zidovudine

1999
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:1

    Topics: Anti-HIV Agents; Candida; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Immune System; Lamivudine; Mumps virus; Ritonavir; RNA, Viral; Zidovudine

2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.
    AIDS (London, England), 2000, Jan-07, Volume: 14, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemocyanins; Hepatitis A Vaccines; HIV-1; Humans; Hypersensitivity, Delayed; Injections, Intradermal; Lamivudine; Male; Middle Aged; Ritonavir; T-Lymphocytes; Tetanus Toxoid; Thymus Gland; Vaccination; Viral Hepatitis Vaccines; Zidovudine

2000
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:1

    Topics: Adult; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Eosinophilia; Female; Follow-Up Studies; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Hypersensitivity, Delayed; Interleukin-2; Intradermal Tests; Killer Cells, Natural; Leukocyte Count; Lymphocyte Activation; Male; Receptors, Interleukin-2; T-Lymphocytes, Regulatory; Viral Core Proteins; Zidovudine

1991

Other Studies

5 other study(ies) available for zidovudine and Delayed Hypersensitivity

ArticleYear
Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection.
    The Journal of infectious diseases, 1993, Volume: 167, Issue:2

    Topics: Adult; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Injections, Intradermal; Interleukin-2; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukocyte Count; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Zidovudine

1993
Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients.
    AIDS (London, England), 1992, Volume: 6, Issue:11

    Topics: AIDS-Related Opportunistic Infections; Antigens, Bacterial; HIV Infections; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Mycobacterium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculin; Zidovudine

1992
Delayed-type hypersensitivity skin testing in patients with HIV infection.
    AIDS (London, England), 1991, Volume: 5, Issue:1

    Topics: HIV Infections; Humans; Hypersensitivity, Delayed; Leukocyte Count; Skin Tests; T-Lymphocyte Subsets; Zidovudine

1991
Correction of human immunodeficiency virus-associated depression of delayed-type hypersensitivity (DTH) after zidovudine therapy: DTH, CD4+ T-cell numbers, and epidermal Langerhans cell density are independent variables.
    Clinical immunology and immunopathology, 1990, Volume: 55, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Biopsy; CD4 Antigens; Cell Count; Humans; Hypersensitivity, Delayed; Langerhans Cells; Leukocyte Count; Male; Skin; T-Lymphocytes; Zidovudine

1990
Heightened cutaneous reactions to mosquito bites in patients with acquired immunodeficiency syndrome receiving zidovudine.
    Archives of internal medicine, 1988, Volume: 148, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Culicidae; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Insect Bites and Stings; Leukocyte Count; Male; T-Lymphocytes; Zidovudine

1988